Previous Close | 0.2550 |
Open | 0.2600 |
Bid | 0.2350 x N/A |
Ask | 0.2450 x N/A |
Day's Range | 0.2250 - 0.2650 |
52 Week Range | 0.2250 - 2.0600 |
Volume | |
Avg. Volume | 728,713 |
Market Cap | 116.343M |
Beta (5Y Monthly) | 1.41 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
NEW YORK, June 11, 2024--The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQX: CBSTF) (FSE: 3LP) ("The Cannabist Company" or the "Company"), one of the most experienced cultivators, manufacturers, and retailers of cannabis products in the U.S., today announced it has opened its newest dispensary in Richmond, Virginia. Cannabist Richmond, located at 4320 S Laburnum Ave., will serve registered medical patients.
NEW YORK, May 16, 2024--The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQX: CBSTF) (FSE: 3LP) ("The Cannabist Company" or the "Company"), one of the largest and most experienced cultivators, manufacturers, and retailers of cannabis products in the U.S., released the following statements in response to President Biden and his administration’s decision to move cannabis from a Schedule I Controlled Substance to a Schedule III Controlled Substance under the federal Controlled Substances Act.
NEW YORK, May 09, 2024--The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQX: CBSTF) (FSE: 3LP) ("The Cannabist Company" or the "Company"), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today reported its financial and operating results for the first quarter ended March 31, 2024. All financial information presented in this release is in U.S. GAAP and in thousands of U.S. dollars, unless otherwise noted.